ROBERT L. SWEZEY, M.D.; JAMES PATTERSON, M.D.; STANLEY MARCUS, M.D.; DAVID STRANGE, M.D.; MELVIN H. LEVIN, M.D,.
The purpose of this paper is to describe the clinical manifestations of rheumatoid spondylitis and its impact upon the social and economic life of the individual. Inferences as to its precise relationship to other arthritic and collagen diseases will be left to the reader and future investigators. The exact characterization of the disease which we in the United States choose to call "rheumatoid spondylitis," and which in Europe is generally referred to as "ankylosing spondylitis,"1 has been a subject of contention for many years.
The first reported description of what we now recognize as rheumatoid spondylitis was by Bernard
SWEZEY RL, PATTERSON J, MARCUS S, et al. RHEUMATOID SPONDYLITIS: A CLINICAL AND SOCIO-ECONOMIC STUDY*. Ann Intern Med. 1957;47:904–921. doi: https://doi.org/10.7326/0003-4819-47-5-904
Download citation file:
Published: Ann Intern Med. 1957;47(5):904-921.
Infectious Disease, Rheumatology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use